ATARA BIOTHERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-220.5M | $-231.1M | $10.6M | $53.9M |
| FY2022 | $-270.4M | $-274.6M | $4.2M | $53.8M |
| FY2023 | $-193.0M | $-194.2M | $1.2M | $45.4M |
| FY2024 | $-68.7M | $-69.0M | $246.0K | $27.0M |
| FY2025 | $-50.9M | $-50.9M | $0 | $9.8M |